Early Vitrectomy vs Laser for Early Diabetic Eye Disease
Part of Eyes & vision clinical trials.
This trial compares two treatments for early diabetic retinopathy—a condition where high blood sugar damages blood vessels in the eye. Researchers want to see if removing fluid from inside the eye (vitrectomy) works better than laser treatment to prevent vision loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- You have early proliferative diabetic retinopathy (new abnormal blood vessels in the eye) with some bleeding that doesn't block vision
- Your eye is clear enough for laser treatment and imaging
- You have not had previous eye laser or surgery for this condition
- Your blood sugar and blood pressure are reasonably controlled
- You can commit to multiple follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches to treat advanced diabetic eye disease (proliferative diabetic retinopathy): injections of faricimab plus laser, versus surgery (vitrectomy) with laser. It is for people with diabetes who need treatment for PDR and still have relatively good vision (20/100 or better) in the affected eye.
This study looks at how well surgery called vitrectomy works for people with severe nonproliferative diabetic retinopathy (NPDR), a condition where high blood sugar damages the retina. The trial aims to see if this surgery can improve vision and outcomes.
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
This trial is testing a new laser treatment pattern for people with diabetic eye disease (proliferative diabetic retinopathy) to see if it works better than the standard approach. If you have this condition and want a less invasive treatment option, this study might be a good fit.
This study tests whether using a special eye scan (OCTA) to guide targeted laser treatment can slow down the progression of areas with poor blood flow in the retina of people with diabetic retinopathy. The goal is to prevent the condition from getting worse and help preserve your vision.
This trial tests whether giving bevacizumab (a medicine that slows abnormal blood vessel growth) right after vitrectomy (a surgery to remove blood or scar tissue from the eye) can help people with advanced diabetic eye disease. The goal is to improve vision and reduce the need for more treatments.
Hear when a new Proliferative Diabetic Retinopathy (PDR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.